OSTX
Price:
$1.82
Market Cap:
$64.09M
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
Industry
Biotechnology
IPO Date
2024-08-01
Stock Exchange
NYSE
Ticker
OSTX
According to OS Therapies Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is -2.25. This represents a change of -80.80% compared to the average of -11.72 of the last 4 quarters.
The mean historical PE Ratio of OS Therapies Incorporated over the last ten years is -708.20. The current -2.25 PE Ratio has changed -68.23% with respect to the historical average. Over the past ten years (40 quarters), OSTX's PE Ratio was at its highest in in the March 2025 quarter at -0.00. The PE Ratio was at its lowest in in the March 2022 quarter at -4493.07.
Average
-708.20
Median
-9.27
Minimum
-3507.42
Maximum
-6.46
Discovering the peaks and valleys of OS Therapies Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 55.69%
Maximum Annual PE Ratio = -6.46
Minimum Annual Increase = -99.78%
Minimum Annual PE Ratio = -3507.42
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -10.06 | 55.69% |
| 2023 | -6.46 | -30.33% |
| 2022 | -9.27 | 18.64% |
| 2021 | -7.81 | -99.78% |
The current PE Ratio of OS Therapies Incorporated (OSTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.59
5-year avg
-708.20
10-year avg
-708.20
OS Therapies Incorporated’s PE Ratio is less than Spruce Biosciences, Inc. (-1.13), less than Werewolf Therapeutics, Inc. (-0.63), less than Outlook Therapeutics, Inc. (-1.75), less than IO Biotech, Inc. (-0.51), greater than CervoMed Inc. (-3.59), less than MiNK Therapeutics, Inc. (-0.01), greater than Equillium, Inc. (-2.33), greater than Coeptis Therapeutics, Inc. (-8.96), less than Adagene Inc. (-1.93), less than NRx Pharmaceuticals, Inc. (-1.43),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.13 | $52.49M | |
| -0.63 | $48.35M | |
| -1.75 | $91.50M | |
| -0.51 | $48.79M | |
| -3.59 | $83.83M | |
| -0.01 | $57.97M | |
| -2.33 | $30.99M | |
| -8.96 | $57.70M | |
| -1.93 | $74.28M | |
| -1.43 | $42.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OS Therapies Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OS Therapies Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is OS Therapies Incorporated's PE Ratio?
How is the PE Ratio calculated for OS Therapies Incorporated (OSTX)?
What is the highest PE Ratio for OS Therapies Incorporated (OSTX)?
What is the 3-year average PE Ratio for OS Therapies Incorporated (OSTX)?
What is the 5-year average PE Ratio for OS Therapies Incorporated (OSTX)?
How does the current PE Ratio for OS Therapies Incorporated (OSTX) compare to its historical average?